[{"uuid": "b92efa31-434d-32f6-91f2-cb0c02e0fc37", "title": "Here\u2019s Why Aligos Therapeutics, Inc. (ALGS) Is Skyrocketing", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-aligos-therapeutics-inc-algs-213251357.html", "providerPublishTime": 1736803971, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/3OmMjF_QkSoX2pLtZqARyg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/952222b241dc0b7b89cc5cfbd12136d8", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/cOD_9KmknQv9jK5M1RafNQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/952222b241dc0b7b89cc5cfbd12136d8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALGS"]}, {"uuid": "229789fa-1845-3c24-ae22-341fc74dab2c", "title": "Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/mirum-pharmaceuticals-announces-preliminary-unaudited-133000951.html", "providerPublishTime": 1736775000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/YMPjEs8g3MoRHK.YyoL3ww--~B/aD0yODA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/1a0b88e719a6d1110b230eedd4cbb15f", "width": 480, "height": 280, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/r6YZFJyEknenfFs7ctuBcg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/1a0b88e719a6d1110b230eedd4cbb15f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["MIRM"]}, {"uuid": "48baf822-ab53-3c01-9656-8da7e2dad8eb", "title": "Palantir, AppLovin Among The 100 Best Stocks Of 2024", "publisher": "Investor's Business Daily", "link": "https://finance.yahoo.com/m/48baf822-ab53-3c01-9656-8da7e2dad8eb/palantir%2C-applovin-among-the.html", "providerPublishTime": 1735689179, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/hjxZMZ_QIvHiSrEyZpWdyA--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/0fb860a2061ad3c9dfb19fcf9128da8e", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/d7dgMb.HlsQZRoy1ZqpOpA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/0fb860a2061ad3c9dfb19fcf9128da8e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALAB", "TLN", "PLTR", "VST", "APP"]}, {"uuid": "1cbd216a-f5d6-32c1-ab15-e1a28ab3ba9a", "title": "Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) biggest owners are retail investors who got richer after stock soared 17% last week", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/aligos-therapeutics-inc-nasdaq-algs-134309108.html", "providerPublishTime": 1734788589, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/eZ0FiSKCVDYnTK6X1bRieQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALGS"]}, {"uuid": "34af9176-bbc1-34af-9adf-4dd9ff02d1bd", "title": "Aligos Therapeutics, Inc. (ALGS) Reports Q3 Loss, Tops Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/aligos-therapeutics-inc-algs-reports-230507639.html", "providerPublishTime": 1730934307, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/kz0ozt3ejWMPXKci2JxOBw--~B/aD03NTQ7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9", "width": 1000, "height": 754, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9DuI9CAB81x7COnzMbUTGw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALGS"]}, {"uuid": "c3574b17-8c1c-3908-9eb5-3e480e1b01f2", "title": "Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aligos-therapeutics-announces-inducement-grants-130000637.html", "providerPublishTime": 1734094800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/H3i0wkXztXJpDIp4LZ0spg--~B/aD01MDt3PTE1MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/3effef0e914cf3a3df127b306a99de95", "width": 150, "height": 50, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/I7KL0GkcaPj8p02IzAdChw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3effef0e914cf3a3df127b306a99de95", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALGS"]}, {"uuid": "d7f90b89-89ee-3e35-aa8a-62782658b813", "title": "Aligos Therapeutics Reports Recent Business Progress and\u00a0Third Quarter 2024 Financial Results", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aligos-therapeutics-reports-recent-business-210500108.html", "providerPublishTime": 1730927100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/H3i0wkXztXJpDIp4LZ0spg--~B/aD01MDt3PTE1MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/3effef0e914cf3a3df127b306a99de95", "width": 150, "height": 50, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/I7KL0GkcaPj8p02IzAdChw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3effef0e914cf3a3df127b306a99de95", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALGS"]}, {"uuid": "1dbd76f2-49c8-31f5-b3f8-85c8e1837ee9", "title": "Bylvay\u00ae (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/bylvay-odevixibat-data-shows-sustained-060000611.html", "providerPublishTime": 1731909600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/NGuJAdc3cTnVKJwSV6LVjQ--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0859d3e9de29c3c0ec9ff9c9af29edb9", "width": 1200, "height": 628, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/3VmOKIm21O37tpZlFxGWsw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0859d3e9de29c3c0ec9ff9c9af29edb9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["IPSEF", "IPSEY"]}, {"uuid": "c19870a8-6f20-3c69-a032-9d91f957e9a7", "title": "Aligos Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/aligos-therapeutics-third-quarter-2024-125141067.html", "providerPublishTime": 1731243101, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c", "width": 945, "height": 636, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/NamfX5LEtyScIu4YmRG2hg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALGS"]}, {"uuid": "8f6c0edd-0466-3d0b-849f-70c3d7ab592f", "title": "Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aligos-therapeutics-presents-positive-data-183000009.html", "providerPublishTime": 1732041000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/H3i0wkXztXJpDIp4LZ0spg--~B/aD01MDt3PTE1MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/3effef0e914cf3a3df127b306a99de95", "width": 150, "height": 50, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/I7KL0GkcaPj8p02IzAdChw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3effef0e914cf3a3df127b306a99de95", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALGS"]}, {"uuid": "3bdde3c6-d8e3-3ea8-993d-3eeda13c346e", "title": "Aligos Therapeutics to Present at Investor Conferences in December", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aligos-therapeutics-present-investor-conferences-130000921.html", "providerPublishTime": 1732626000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/H3i0wkXztXJpDIp4LZ0spg--~B/aD01MDt3PTE1MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/3effef0e914cf3a3df127b306a99de95", "width": 150, "height": 50, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/I7KL0GkcaPj8p02IzAdChw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3effef0e914cf3a3df127b306a99de95", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALGS"]}, {"uuid": "11d703d8-1ef4-30a6-9048-fa2b44d50ed1", "title": "Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-third-quarter-130000190.html", "providerPublishTime": 1731416400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/LOUiQ5wXNzaJ0nZY1aPj6g--~B/aD0yODA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c4fef758562f23ecbdf89f03ea9a3983", "width": 480, "height": 280, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/5z6lKnoLorGzFL5eRfo8CQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/c4fef758562f23ecbdf89f03ea9a3983", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["MIRM"]}]